Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer's series B round to $35.9m, following a Novartis-led tranche a year ago.

Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.

Lundbeckfonden Ventures and Alexandria Venture Investments both backed a series A round for tumour and endocrine disease drug developer Tiburio.

GE Ventures’ director of healthcare investments, Jessica Zeaske, has left for a partner role at corporate-backed investment vehicle Echo Health Ventures.

Alexandria Venture Investments has taken part in the final close of the series B round, which will fund development of the company's cell therapy platform.

Martlet has reinvested in Exonate through a $1.8m funding round that increased the retinal eye drop maker's total funding to more than $11m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Eli Lilly-backed biotech companies HJB and MabSpace have agreed to merge into a newly formed business called Transcenta.

Silver Lake and Ontario Teachers’ Pension Plan backed a round that will fund acquisitions for Verily as well as the expansion of its strategic partnerships.

UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.